The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10481 malaria professionals are enjoying the free benefits of MalariaWorld today

severe anaemia

Intermittent preventive therapy for malaria with monthly artemether–lumefantrine for the post-discharge management of severe anaemia in children aged 4–59 months in southern Malawi: a multicentre, randomised, placebo-controlled trial

February 24, 2012 - 13:16 -- Patrick Sampao
Kamija Phiri, Michael Esan, Michael Boele van Hensbroek, Carole Khairallah, Brian Faragher, Feiko O ter Kuile
The Lancet Infectious Diseases, Volume 12, Issue 3, March 2012, Pages 191-200

MalariaWorldWe aimed to assess whether 3 months of chemoprevention with artemether–lumefantrine reduced this risk.

Medical Condition: 
Medical Treatment: 

Open Access | The ABO blood group and Plasmodium falciparum malaria in Awash, Metehara and Ziway areas, Ethiopia

October 16, 2010 - 08:19 -- Kabogo Ndegwa
Tekeste Z, Petros B
Malaria Journal 2010, 9:280 (12 October 2010)

The study revealed that on the basis of the three criteria (cerebral malaria, severe anaemia and circulatory collapse) used to determine severity in P. falciparum malaria, patients with blood group O, which is less prone to rosetting have a reduced chance of developing severe falciparum malaria as compared to patients with other blood groups.

Subscribe to RSS - severe anaemia